| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +5,450% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +172% |
| 3Y CAGR | -45% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Neuland LaboratoriesNEULANDLAB | ₹17,198.00 +225.00 (1.33%) | 22,038.54 | 60.55 | 11.76 | ||
PfizerPFIZER | ₹4,509.20 -63.70 (1.39%) | 20,631.77 | 28.56 | 4.91 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹8,249.50 +21.00 (0.26%) | 20,609.75 | 109.9 | 23.61 | ||
₹1,404.60 +39.00 (2.86%) | 19,439.60 | 30.02 | 4.98 |